Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as C$0.13 and last traded at C$0.13, with a volume of 192568 shares traded. The stock had previously closed at C$0.15.
Voyageur Pharmaceuticals Stock Performance
The company has a quick ratio of 0.84, a current ratio of 0.58 and a debt-to-equity ratio of 2.77. The stock has a market cap of C$26.77 million, a P/E ratio of -7.50 and a beta of 0.78. The firm’s 50-day moving average is C$0.16 and its two-hundred day moving average is C$0.16.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- The “secret weapon” behind Microsoft, Meta, Amazon, and Google
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- The U.S. Military’s “Ace Card” For Iran
- Iran isn’t the real war
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
